Juvenescence
ID: 5842034Juvenescence is an AI-driven drug discovery platform founded in 2016 by Jim Mellon, Declan Doogan and Greg Bailey.
5
Funding Rounds
$238.3m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ji* Me**** |
|
- | |
| De**** Do**** |
|
- | - |
| Gr** Ba**** |
|
- | - |
Funding series
Funding Series Analysis
The company Juvenescence has raised a total of $76m in funding over 5 rounds.
Key Insights:
- Juvenescence Series B Round, May 2025: $76m
- Juvenescence funding round, August 2019: $100m
- Juvenescence funding round, June 2018: $50m
- Juvenescence funding round, January 2018: $12.3m
Industries
Juvenescence is active in the following industries: